Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why isn’t medical advertising regulated like other advertising?

Martha Rosenberg
Meds
September 7, 2024
Share
Tweet
Share

As long as you live, you will never hear an article from news media contending that “America Runs On Duncan.” Why? Because the line is a marketing allegation created by the advertising company and designed to sell product.

Yet news media repeat medical claims from drug makers found in journals like they are news––which gives Pharma companies free advertising and can mislead consumers and patients.

The most recent example is the “news” that the shingles vaccine may lower the risk of dementia. What is the “source” of the news?  Researchers affiliated with the University of Oxford, which boasts a five-year collaboration with GSK, the vaccine’s manufacturer! Who can say conflict of interest? The assertion may well prove to be true down the road, but right now, it is just a sales message.

Another example of marketing somehow elevated to “news” is the new benefits found with glucagon-like peptide 1 (GLP-1) agonists, rapid-weight loss drugs like Ozempic (semaglutide)–specifically a reduction in addiction behaviors.  (Not that the drugs need a sales boost!)

What is the source of the mental health benefit allegations? Research published in the British Journal of Pharmacology, one of whose authors received “an unrestricted research grant from [Ozempic maker] Novo Nordisk A/S to investigate the effects of GLP‐1 receptor stimulation on metabolic disturbances and weight gain in antipsychotic‐treated patients with schizophrenia.” No conflict there.

News that GLP-1 agonists protect against dementia/Alzheimer’s, presented at the 2024 Alzheimer’s conference, also poses  problematical links. The investigator for the trials behind the “news,” Paul Edison, “collaborates closely with Novo Nordisk, GE Healthcare, Novartis, Piramal Life Sciences, and Astra Zeneca,” according to his faculty page at Imperial College.

Who remembers Xolair, an injected asthma drug manufactured by Genentech and Novartis, when the asthma “space” was especially lucrative? (See Advair, Singulair, Symbicort.) After its launch, whistleblowers approached me and revealed that they were instructed to illegally market the drug to children. Meanwhile, the drug was found to have a new benefit of treating urticaria (hives–itchy, raised bumps or welts on the skin) by, well researchers funded by Novartis.

Medical journals do not make it easy to root out these conflicts of interest. Many hide conflict of interest disclosures behind paywalls. Others confusingly refer to drug-maker-funded researchers only by their initials. Why? Still, other journals list government funding, such as from the National Heart, Lung, and Blood Institute (NHLBI), as if it were a conflict of interest designed to sell a drug in the way drug maker-funded research floating new drug benefits is.

While direct-to-consumer ads seem to dominate TV, they are for FDA-approved drug uses; it is illegal for drug makers to advertise a drug for non-FDA-approved use. (Though it is legal for doctors to prescribe a drug for a non-approved use or indication.) Moreover, procuring a new FDA approval for a drug takes years and millions in investment. That’s why floating a new benefit in medical journals that are picked up by news media is so tempting and common. It works.

Yet news media invariably pick up and publish medical stories—especially those describing a “new benefit” to an existing drug published in a medical journal—without even investigating their tautological source: the drug manufacturer! How is this different from writing a story whose lead-in is “America Runs On Duncan”?

Martha Rosenberg is a health reporter and the author of Big Food, Big Pharma, Big Lies and Born With a Junk Food Deficiency.  

Prev

The heartbreaking reality of smoking: a daughter's final goodbye

September 7, 2024 Kevin 0
…
Next

Time to get digital in your practice

September 7, 2024 Kevin 1
…

Tagged as: Medications

Post navigation

< Previous Post
The heartbreaking reality of smoking: a daughter's final goodbye
Next Post >
Time to get digital in your practice

ADVERTISEMENT

More by Martha Rosenberg

  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • Conflicts of interest are eroding trust in U.S. health agencies

    Martha Rosenberg
  • How drug companies turned “depression” into a billion-dollar industry

    Martha Rosenberg

Related Posts

  • Major medical groups back mandatory COVID vaccine for health care workers

    Molly Walker
  • How the COVID-19 pandemic highlights the need for social media training in medical education 

    Oscar Chen, Sera Choi, and Clara Seong
  • What is anti-racist medical education?

    Sylk Sotto, EdD, MPS, MBA
  • Drug advertising has helped created victim politics

    Martha Rosenberg
  • Medical school gap year: Why working as a medical assistant is perfect

    Natalie Enyedi
  • End medical school grades

    Adam Lieber

More in Meds

  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • The food-drug interaction risks your doctor may be missing

    Frank Jumbe
  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Why point-of-care ultrasound belongs in every emergency department triage [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why PSA levels alone shouldn’t define your prostate cancer risk

      Martina Ambardjieva, MD, PhD | Conditions
    • How to handle chronically late patients in your medical practice

      Neil Baum, MD | Physician
    • Reframing chronic pain and dignity: What a pain clinic teaches us about MAiD and chronic suffering

      Olumuyiwa Bamgbade, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • Why medicine must evolve to support modern physicians

      Ryan Nadelson, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Why point-of-care ultrasound belongs in every emergency department triage [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why PSA levels alone shouldn’t define your prostate cancer risk

      Martina Ambardjieva, MD, PhD | Conditions
    • How to handle chronically late patients in your medical practice

      Neil Baum, MD | Physician
    • Reframing chronic pain and dignity: What a pain clinic teaches us about MAiD and chronic suffering

      Olumuyiwa Bamgbade, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • Why medicine must evolve to support modern physicians

      Ryan Nadelson, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Why isn’t medical advertising regulated like other advertising?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...